Free Trial
TSE:ACB

Aurora Cannabis 2/8/2024 Earnings Report

Aurora Cannabis logo
C$6.47 -0.21 (-3.14%)
As of 04:00 PM Eastern

Aurora Cannabis EPS Results

Actual EPS
-C$0.20
Consensus EPS
-C$0.10
Beat/Miss
Missed by -C$0.10
One Year Ago EPS
N/A

Aurora Cannabis Revenue Results

Actual Revenue
$72.61 million
Expected Revenue
$63.50 million
Beat/Miss
Beat by +$9.11 million
YoY Revenue Growth
N/A

Aurora Cannabis Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Aurora Cannabis Earnings Headlines

Massive red flag about American consumer
Why is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U.S. dollar would crash for years. In 2025, it looks like it finally is. What does that mean for you money... and was this President Trump's plan all along? A widely followed 25-year economist and investor explains exactly what's happening, what could come next, and how to position your money on this page here.
Is Aurora Cannabis stock a good buy right now?
See More Aurora Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email.

About Aurora Cannabis

Aurora Cannabis (TSE:ACB), headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

View Aurora Cannabis Profile

More Earnings Resources from MarketBeat